Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 3/2012

01-03-2012 | Article

Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study

Authors: T. Lind, I. Waernbaum, Y. Berhan, G. Dahlquist

Published in: Diabetologia | Issue 3/2012

Login to get access

Abstract

Aims/hypothesis

Mood disorders, including depression, are suggested to be prevalent in persons with type 1 diabetes and may negatively affect self-management and glycaemic control and increase the risk of diabetic complications. The aim of this study was to analyse the prevalence of antidepressant (AD) use in adults with childhood onset type 1 diabetes and to compare risk determinants for AD prescription among diabetic patients and a group of matched controls.

Methods

Young adults ≥18 years on 1 January 2006 with type 1 diabetes (n = 7,411) were retrieved from the population-based Swedish Childhood Diabetes Registry (SCDR) and compared with 30,043 age- and community-matched controls. Individual level data were collected from the Swedish National Drug Register (NDR), the Hospital Discharge Register (HDR) and the Labor Market Research database (LMR).

Results

ADs were prescribed to 9.5% and 6.8% of the type 1 diabetes and control subjects, respectively. Female sex, having received economic or other social support, or having a disability pension were the factors with the strongest association with AD prescription in both groups. Type 1 diabetes was associated with a 44% (OR 1.44, 95% CI 1.32, 1.58) higher risk of being prescribed ADs in crude analysis. When adjusting for potential confounders including sex, age and various socioeconomic risk factors, this risk increase was statistically non-significant (OR 1.11, 95% CI 0.99, 1.21).

Conclusions/interpretation

The risk factor patterns for AD use are similar among type 1 diabetic patients and controls, and socioeconomic risk factors, rather than the diabetes per se, contribute to the increased risk of AD use in young adults with type 1 diabetes.
Literature
1.
Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19:113–122PubMed
2.
van Tilburg MA, McCaskill CC, Lane JD et al (2001) Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med 63:551–555PubMed
3.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078PubMedCrossRef
4.
Barnard KD, Skinner TC, Peveler R (2006) The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med 23:445–448PubMedCrossRef
5.
Lawrence JM, Standiford DA, Loots B et al (2006) Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth Study. Pediatrics 117:1348–1358PubMedCrossRef
6.
Kovacs M, Goldston D, Obrosky DS, Bonar LK (1997) Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care 20:36–44PubMedCrossRef
7.
Popkin MK, Callies AL, Lentz RD, Colon EA, Sutherland de (1988) Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry 45:64–68PubMedCrossRef
8.
Petrak F, Hardt J, Wittchen HU et al (2003) Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. Diabetes Metab Res Rev 19:216–222PubMedCrossRef
9.
Kokkonen E-R (1995) Mental health and social adaptation in young adults with juvenile-onset diabetes. Nordic J Psychiatr 49:175–181CrossRef
10.
Lustman PJ, Griffith LS, Clouse RE et al (1995) Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial. Diabetes Care 18:1133–1139PubMedCrossRef
11.
Lustman PJ, Griffith LS, Clouse RE et al (1997) Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250PubMed
12.
Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE (1997) Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 59:24–31PubMed
13.
Garrison CZ, Addy CL, Jackson KL, McKeown RE, Waller JL (1992) Major depressive disorder and dysthymia in young adolescents. Am J Epidemiol 135:792–802PubMed
14.
Goodman E (1999) The role of socioeconomic status gradients in explaining differences in US adolescents’ health. Am J Public Health 89:1522–1528PubMedCrossRef
15.
Roberts RE, Roberts CR, Chen YR (1997) Ethnocultural differences in prevalence of adolescent depression. Am J Community Psychol 25:95–110PubMedCrossRef
16.
Hansen DG, Sondergaard J, Vach W et al (2004) Socio-economic inequalities in first-time use of antidepressants: a population-based study. Eur J Clin Pharmacol 60:51–55PubMedCrossRef
17.
Berhan Y, Waernbaum I, Lind T, Möllsten A, Dahlquist G (2011) Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 60:577–581PubMedCrossRef
18.
Dahlquist G, Mustonen L (2000) Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group. Acta Paediatr 89:1231–1237PubMedCrossRef
19.
Wallgren A, Wallgren B (2007) Register-based statistics: administrative data for statistical purposes. Wiley, Chichester
20.
21.
22.
The National Board of Health and Welfare (2003) A finger on the pulse. Monitoring public health and social conditions in Sweden 1992–2002. In: Rosén M (ed). The National Board of Health and Welfare, Stockholm
23.
Ury HK (1975) Efficiency of case–control studies with multiple controls per case: continuous or dichotomous data. Biometrics 31:643–649PubMedCrossRef
24.
World Health Organization Collaborating Centre for Drug Statistics Methodology (2011) ATC/DDD Index 2011. www.​whocc.​no/​. Accessed 9 September 2011
25.
The National Board of Health and Welfare (2007) Pharmaceuticals—statistics for 2006. In: Eriksson Ö (ed). The National Board of Health and Welfare, Stockholm
26.
Statistics Sweden (2011) Background facts, labour and education statistics 2011:4. In: Integrated database for labour market research. SCB, Stockholm
27.
28.
Inspektionen för socialförsäkringen (2011) Unga med aktivitetsersättning. In: Inspektionen för socialförsäkringen, Stockholm (in Swedish)
29.
Li X, Sundquist J, Sundquist K (2008) Age-specific familial risks of depression: a nation-wide epidemiological study from Sweden. J Psychiatr Res 42:808–814PubMedCrossRef
30.
Barrera MJ, Prelow HM, Dumka LE et al (2002) Pathways from family economic conditions to adolescents’ distress: supportive parenting, stressors outside the family, and deviant peers. J Community Psychol 30:135–152CrossRef
31.
Currie J (2009) Healthy, wealthy, and wise: socioeconomic status, poor health in childhood, and human capital development. J Econ Lit 47:87–122CrossRef
32.
Sundquist K, Johansson LM, Johansson SE, Sundquist J (2004) Social environment and psychiatric illness. A follow-up study of 9,170 women and men in Sweden. Soc Psychiatr Psychiatr Epidemiol 39:39–44CrossRef
33.
Milton B, Holland P, Whitehead M (2006) The social and economic consequences of childhood-onset type 1 diabetes mellitus across the lifecourse: a systematic review. Diabet Med 23:821–829PubMedCrossRef
34.
Kakleas K, Kandyla B, Karayianni C, Karavanaki K (2009) Psychosocial problems in adolescents with type 1 diabetes mellitus. Diabetes Metab 35:339–350PubMedCrossRef
35.
Dahlquist G, Kallen B (2007) School performance in children with type 1 diabetes—a population-based register study. Diabetologia 50:957–964PubMedCrossRef
36.
Dahlquist G, Kallen B (2007) School marks for Swedish children whose mothers had diabetes during pregnancy: a population-based study. Diabetologia 50:1826–1831PubMedCrossRef
37.
Henriksson S, Boethius G, Hakansson J, Isacsson G (2003) Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jamtland county, Sweden, 1995. Acta Psychiatr Scand 108:427–431PubMedCrossRef
38.
van der Feltz-Cornelis CM, Nuyen J, Stoop C et al (2010) Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 32:380–395PubMedCrossRef
39.
Manderbacka K, Sund R, Koski S, Keskimaki I, Elovainio M (2011) Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997–2007. Pharmacoepidemiol Drug Saf 20:338–343PubMedCrossRef
40.
Sundell KA, Gissler M, Petzold M, Waern M (2011) Antidepressant utilization patterns and mortality in Swedish men and women aged 20–34 years. Eur J Clin Pharmacol 67:169–178PubMedCrossRef
41.
Gendelman N, Snell-Bergeon JK, McFann K et al (2009) Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care 32:575–579PubMedCrossRef
Metadata
Title
Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study
Authors
T. Lind
I. Waernbaum
Y. Berhan
G. Dahlquist
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2405-0

Other articles of this Issue 3/2012

Diabetologia 3/2012 Go to the issue

Article

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

Article

Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle

Article

The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial

Then and Now

What’s new since Hippocrates? Preventing type 2 diabetes by physical exercise and diet

Erratum

Erratum to: Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase

Meta-analysis

Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits